Simcere Pharmaceutical Group Limited (FRA:S2P)
Germany flag Germany · Delayed Price · Currency is EUR
1.250
+0.030 (2.46%)
At close: Jan 30, 2026

FRA:S2P Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2,6711,9432,0071,658973.143,270
Short-Term Investments
5.72-11.14964.231,210-
Trading Asset Securities
-----3.63
Cash & Short-Term Investments
2,6761,9432,0182,6232,1833,274
Cash Growth
-12.44%-3.73%-23.04%20.12%-33.31%263.04%
Accounts Receivable
2,6382,7042,6452,3392,3991,871
Other Receivables
76.460.0650.7339.8937.3743.79
Receivables
2,7152,7642,6952,3792,4361,915
Inventory
658.73683.97770.14371.59290.96311.13
Other Current Assets
65.3974.21155.1385.6169.24967.03
Total Current Assets
6,1155,4665,6395,4584,9806,467
Property, Plant & Equipment
2,2662,2702,1702,1391,9312,128
Long-Term Investments
1,8911,8931,5802,2582,6511,825
Goodwill
142.47142.47142.47172.79172.79172.79
Other Intangible Assets
1,3891,025715.79379.959.6977.11
Long-Term Deferred Tax Assets
519.59435.59317326.71289.97210.09
Other Long-Term Assets
181.73178.19188.9553.7976.5663.53
Total Assets
12,60511,51010,85410,78910,16110,943
Accounts Payable
187.91275.73317.22335.43323.95242.08
Accrued Expenses
846.841,0311,0451,1241,0321,155
Short-Term Debt
1,0501,050762.431,184991.571,561
Current Portion of Long-Term Debt
0.710.72252.71108.37538.51232.2
Current Portion of Leases
79.1567.5679.8558.7631.5638.1
Current Income Taxes Payable
88.96154.3617.910.5616.16-
Current Unearned Revenue
383.2228.1643.3163.3426.1418.76
Other Current Liabilities
891.77119.2516782.41103.7249.91
Total Current Liabilities
3,5292,7272,6862,9673,0643,497
Long-Term Debt
7.898.25205.85--1,276
Long-Term Leases
91.6982.42128.4155.9274.24193.43
Long-Term Unearned Revenue
366.28377.69393.11403.35417.61447.95
Long-Term Deferred Tax Liabilities
67.5872.7102.68115.29142.77193.6
Other Long-Term Liabilities
1,3091,174115---
Total Liabilities
5,3714,4423,6313,6413,6985,608
Common Stock
3,1843,1743,1743,0813,0033,003
Retained Earnings
3,6203,4813,8373,8313,2942,147
Comprehensive Income & Other
430.28413.29211.61219.72139.96151.48
Total Common Equity
7,2347,0687,2237,1326,4375,302
Minority Interest
---16.0625.7633.94
Shareholders' Equity
7,2347,0687,2237,1486,4635,336
Total Liabilities & Equity
12,60511,51010,85410,78910,16110,943
Total Debt
1,2301,2091,4291,5071,6363,300
Net Cash (Debt)
1,447733.7589.081,116547.34-26.14
Net Cash Growth
-22.82%24.55%-47.21%103.86%--
Net Cash Per Share
0.590.290.230.430.21-0.01
Filing Date Shares Outstanding
2,4752,4862,6172,6602,6282,609
Total Common Shares Outstanding
2,4752,4862,6172,6602,6282,609
Working Capital
2,5862,7392,9532,4921,9162,970
Book Value Per Share
2.922.842.762.682.452.03
Tangible Book Value
5,7025,9006,3646,5796,2055,052
Tangible Book Value Per Share
2.302.372.432.472.361.94
Machinery
-2,9612,6322,8112,5282,572
Construction In Progress
-343.38343.47202.1395.7566.43
Source: S&P Global Market Intelligence. Standard template. Financial Sources.